摘要
目的:克隆人血管内皮生长因子(vascularendothelialgrowthfactor165,VEGF165)和血管生成素-1(angiopoietin-1)的全长编码基因,构建表达该基因的复制缺陷型腺病毒载体Ad-Ang1和Ad-VEGF165。方法:通过RT-PCR方法克隆人VEGF165和Ang1全长编码基因。Ad-VEGF165和Ad-Ang1通过同源重组方法构建。将Ad-VEGF165和/或Ad-Ang1转染大鼠胚胎心脏成肌细胞(H9C2)24h后,Westernblot方法分析VEGF165和Ang1蛋白表达量;核酸电泳分析细胞基因组降解检测凋亡水平。结果:测序显示VEGF165序列与基因库序列相同;Ang1序列与基因库序列存在一个碱基的差异,但编码氨基酸无改变。VEGF165和Ang1蛋白表达分别为对照组的11.65倍和3.53倍。Ad-VEGF165和/或Ad-Ang1转染后的H9C2细胞对过氧化氢诱导的细胞凋亡具有明显的抵抗能力。结论:所构建的Ad-Ang1和Ad-VEGF165能有效转染心脏成肌细胞,表达出功能性目的蛋白,具有抗细胞凋亡作用。
AIM:We aimed to clone angiopoietin-1(Ang1)and vascular endothelial growth factor(VEGF)full-length DNAs of human origin and construct replication-deficient adenovirus encoding for either of these two genes which can be potentially served for c linical applications.METHODS:VEGF 165 and Ang1full-length cDNAs of human o rigin were amplified by RT-PCR,verified by sequencing,clo ned into a pShuttle-CMV vector,re-combined with a E1and E3regions doub le-deleted adenovirus,packaged in 293A cells,and purified by ultrac entrifugation.The titers of Ad-Ang1and Ad-VEGF 165 were determined by a tissue culture i nfectious dose 50 method.Expression of Ang1and VEGF 165 proteins in H9C2cardiac my-oblasts was examined by Western blot.To examine the protective properties of Ad-Ang1and Ad-VEGF 165 ,DNA fragmentation induced by H 2 O 2 was analyzed in H9C2cells 24hours after transfection.Ad-GFP served as a vehicle control.RESULTS :Sequencing analysis indicated that there is one base difference at site 1206(t)in Ang1compared with that of GeneBan k(c,U83508)although the coded amino acids are th e same (Ileucine).VEGF 165 cDNA sequence was same as that of GeneBank(AB021221).Western blot showed that protein lev els of Ang1and VEGF 165 were in-creased 3.53and 11.53fold respectively 24h after transfection as com-pared to control.Examination of DNA fragmentation suggested that Ang1and /or VEGF 165 significantly protected H9C2cells from H 2 O 2 induced apoptosis.CONCLUSIONS :The two constructed adenoviral vectors,Ad-Ang1and Ad-VEGF 165 ,functionally expressed target pro teins.We demonstrated,for the first time,th at the combined utilization of Ang1a nd VEGF 165 inhibited apoptosis,in addition to their angiogenesis properties.
出处
《中国临床康复》
CSCD
2003年第3期434-436,共3页
Chinese Journal of Clinical Rehabilitation
基金
hVEGF165/Angiopoietin-1基因转移促血管生成作用的研究(BK2001118)